Wegovy vs Zepbound for Weight Loss: A Physician-Guided Comparison
Wegovy and Zepbound are weekly injectable chronic weight-management medications, but they contain different active ingredients and are not interchangeable. Wegovy contains semaglutide; Zepbound contains tirzepatide.
Side-by-side comparison
| Feature | Wegovy | Zepbound |
|---|---|---|
| Ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Typical injection schedule | Once weekly | Once weekly |
| Additional labeled roles | Formulation-specific cardiovascular and other indications | Moderate-to-severe OSA in eligible adults with obesity |
What changes the decision?
Effectiveness
Head-to-head and separate trials can inform expectations, but averages do not determine an individual result. Tolerated dose, adherence, duration, nutrition, activity and continued access matter.
Administration
Both use gradual escalation. Starting doses are not maintenance doses, and combining either medicine with another GLP-1 or overlapping ingredient is not recommended.
Choosing between them
History of adverse effects, diabetes, cardiovascular disease, sleep apnea, gastrointestinal conditions, pregnancy plans, medication interactions, insurance and cost can change the decision.
Safety questions come first
- Both labels have boxed warnings involving thyroid C-cell tumors in rodents and contraindications for personal or family MTC history or MEN 2.
- Both can cause nausea, vomiting, diarrhea, constipation and abdominal symptoms.
- Pancreatitis, gallbladder disease and dehydration-related kidney injury are important risks.
- Tirzepatide has label-specific oral-contraception guidance after initiation and dose escalation.
Patients should use the current product label and prescriber instructions. Do not start, stop, combine, split, substitute or accelerate prescription treatment independently.
How W8MD can help
W8MD physicians review weight history, prior attempts, medical and medication history, sleep, nutrition, goals, insurance and cost before recommending a plan. Care may include a GLP-1 or dual GIP/GLP-1 medication, a traditional prescription, structured nutrition, sleep evaluation or treatment without medication.
Prescription hub · Medication guide · GLP-1 comparison · Insurance guide · Medical weight loss · W8MD.com
Frequently asked questions
Which produces more weight loss?
Trial averages may favor one treatment in some populations, but the best individual choice must balance expected benefit, risk, tolerance, access and sustainability.
Can I switch?
Sometimes, but the prescriber must plan timing and titration to avoid overlap and dosing errors.
Which costs less?
Net cost depends on benefit design, formulary, dose, pharmacy and available programs.
Evidence and prescribing information
FDA Wegovy label · FDA Zepbound label · FDA drug information · WikiMD anti-obesity medication
Request an appointment
For faster assistance, call Brooklyn at 718-946-5500 or Philadelphia at 215-676-2334. Do not send personal medical details or urgent concerns through this form.
Medical disclaimer: Educational information only; not medical advice or a guarantee of treatment, coverage, availability or results. Medical evaluation is required. Call 911 for an emergency.
You must be logged in to post a comment.